Drug Sponsors Can Help Shape Agenda For FDA/EMA Pediatric ‘Cluster’ Calls

 
• By Sue Sutter
  
The "cluster" calls allow multiple regulators to discuss pediatric drug development issues in-depth. (Shutterstock)

More from Regional Comparisons

More from United States